Loading
Professor of translational oncology who directs the Comprehensive Cancer Center Mainfranken at University Hospital Würzburg.
Professor Ralf C. Bargou is Direktor of the Comprehensive Cancer Center Mainfranken (CCC MF), the oncology centre of excellence of University Hospital Würzburg and the University of Würzburg, and holds the Chair of Translational Oncology. He also serves as Sprecher of the hospital's Onkologisches Zentrum. The CCC MF board includes Deputy Director Christoph-Thomas Germer and Managing Director Jutta Riese.
| Title | Journal | Year |
|---|---|---|
| Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia | Blood | 2018 |
| T cell-engaging therapies — BiTEs and beyond | Nature Reviews Clinical Oncology | 2020 |
| Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study | Journal of Clinical Oncology | 2016 |
Shares the tags leadership, clinician-scientist, cancer-centre.
Shares the tags leadership, clinician-scientist, cancer-centre.
Shares the tags leadership, clinician-scientist, cancer-centre.
Shares the tags leadership, clinician-scientist, cancer-centre.
Shares Multiple myeloma and the tags leadership, clinician-scientist.
Shares Multiple myeloma and the tags leadership, clinician-scientist.
Shares Multiple myeloma and the tags leadership, clinician-scientist.
Shares Multiple myeloma and the tags leadership, clinician-scientist.